Clinical Trial

Evaluating Residual Congestion at Discharge in Acute Heart Failure Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 18, 2025 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Treatment of congestion is one of the main goals in patients hospitalized for acute heart failure. Nevertheless, current evidence shows that decongestion is often not achieved and that residual congestion at discharge is strongly associated with poor outcomes. While this association has been demonstrated, previous studies have primarily focused on single parameters of congestion (physical examination, biomarkers, or imaging features). The aim of the study is to assess residual congestion at discharge using a multiparametric approach and to compare the prognostic value of each evaluation strategy. Additionally, the analysis will be supported by artificial intelligence to develop a multiparametric prognostic algorithm that can provide an improved predictive model compared to standard statistical approaches.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-19.
Trial Details
NCT Number NCT06993220
Lead Sponsor Consorci Sanitari Integral
Conditions Acute Heart Failure (AHF), Congestive Heart Failure(CHF)
Enrollment 500 participants
Start Date 2025-01-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-18